Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, May 6, 2014

Prothena: Recent Sell-Off On Positive Data Creates Buying Opportunity

Prothena Corporation is an early-stage, biotechnology company developing targeted antibody-based therapies for patients with AL amyloidosis , Parkinson's disease, and inflammatory / oncology conditions.

http://ift.tt/1myvpDf

No comments:

Post a Comment

Popular Stem Cell Roundup Posts